Clinical Discernment, Bone Marrow, and Molecular Diagnostics Are Equally Important to Solve the Phenotypic Mimicry among Subtypes of Myeloproliferative Neoplasms
The 2016 WHO classification integrates clinical, bone marrow (BM)-morphology, and molecular features to define disease entities. This together with the advancements in molecular detection and standardization of BM features enable an accurate diagnosis of myeloproliferative neoplasms (MPN) in the maj...
Main Authors: | Susann Schulze, Nadia Jaekel, Christin Le Hoa Naumann, Anja Haak, Marcus Bauer, Claudia Wickenhauser, Haifa Kathrin Al-Ali |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2571-841X/4/3/27 |
Similar Items
-
Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01) -
Non-Classic Myeloproliferative Neoplasms: Are We Really Aware of These Rare Diseases in Daily Practice
by: Serdal Korkmaz
Published: (2017-08-01) -
Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53
by: Qian Wang, et al.
Published: (2020-01-01) -
Disabled, invisible and dismissed—The lived experience of fatigue in people with myeloproliferative neoplasms
by: Ashleigh Bradford, et al.
Published: (2023-01-01) -
Clinical characteristics and symptom burden of Thai myeloproliferative neoplasm patients
by: Naritsara Cherdchoo, et al.
Published: (2023-12-01)